Journalistic Malpractice on Trial: What the Dominion Voting System Tells Us About How the Media Sacrificed their Credibility to Partisan Falsehoods

Journalistic Malpractice on Trial: What the Dominion Voting System Tells Us About How the Media Sacrificed their Credibility to Partisan Falsehoods

While the courts are unlikely to deliver solace from political party propaganda disguised as journalism, they have provided some wisdom. Both Rachel Maddow and Tucker Carlson of MSNBC and Fox News Channel respectively, have been brought to court for spreading false information and were exonerated because the judges concluded that no reasonable person would believe either of them were telling the truth. That is good advice, and viewers would be wise to remember it every time they consider watching cable news.

TRUTH COPS: Leaked Documents Outline DHS’s Plans to Police Disinformation

THE DEPARTMENT OF HOMELAND SECURITY is quietly broadening its efforts to curb speech it considers dangerous, an investigation by The Intercept has found. Years of internal DHS memos, emails, and documents — obtained via leaks, Freedom of Information Act requests, and an ongoing lawsuit, as well as public reports — illustrate an expansive effort by the agency to influence tech platforms.

TRUTH COPS: Leaked Documents Outline DHS’s Plans to Police Disinformation

Related:

Disrupt The Cognitive Infrastructure

H/T: Unorthodox Truth

New COVID Booster Approved From Final Study of Mice, Not Humans, But Using Only Animal Data Is a Needless Gamble

VERIFY: New COVID booster approved from final study of mice, not humans

According to documents on the CDC website, human tests of Moderna’s version of the new booster are still “ongoing.” Right now, there is only final evidence from “8-10 mice” per group.”

The FDA’s website shows for Pfizer the agency also relayed on the final study evidence from “8 mice.” But human trials are also ongoing. So far, the new boosters “showed a similar local reaction and systemic event profile.” That means side effects appear to be about the same including “mild to moderate injection site pain, fatigue, and muscle pain.”

“To advance the Omicron BA.4/BA.5 bivalent vaccine as rapidly as possible, regulators, including the FDA, WHO and EMA, have advised that our submissions be based on safety and immunogenicity data generated in adults with an Omicron BA.1 bivalent vaccine and supported by BA.4/BA.5 bivalent pre-clinical data and BA.4/BA.5 bivalent quality and manufacturing data. These packages follow a similar model to that provided to public health officials who evaluate seasonal flu vaccines each year. Moving forward, this approach may help address the pressing need for vaccines that provide a high level of protection against current and emerging variants of concern so that we can remain vigilant against this evolving virus. The FDA has authorized our Omicron BA.4/BA.5 bivalent vaccine based on clinical data generated in adults with an Omicron BA.1 bivalent vaccine, pre-clinical data with a BA.4/BA.5 bivalent vaccine and BA.4/BA.5 bivalent quality and manufacturing data. Pre-clinical data showed a booster dose of Pfizer and BioNTech’s Omicron BA.4/BA.5- bivalent vaccine generated a strong neutralizing antibody response against Omicron BA.1, BA.2 and BA.4/BA.5 variants, as well as the original wild-type strain. A clinical study investigating the safety, tolerability and immunogenicity of the Omicron BA.4/BA.5 bivalent vaccine in individuals 12 years of age and older is ongoing. Data will be shared with regulators when available. We are facing a virus with an exceptionally high mutation rate, which the nimble mRNA platform is well situated to address. Only the mRNA sequence requires updating to match emerging strains, and utilizing a bivalent vaccine aims to provide broader coverage against known and future COVID-19 variants of concern.”

Related:

Read More »

Thai vaccine study

Video via Dr. John Campbell

References:

Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents

Myocarditis and Sudden Cardiac Death in the Young

Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review

CDC: Vaccines for COVID-19

CDC: COVID-19 Vaccines for Children and Teens

Related:

Vaccine myocarditis update from Thailand

Pfizer Jab Fails It’s CEO, Albert Bourla

The jab that failed on all counts BUT one.

The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.

Chairman and CEO Albert Bourla said Monday that he started taking Pfizer´s Paxlovid pill treatment and is isolating while he recovers.

Pfizer Jab Fails It’s CEO, Albert Bourla

Waiting for the Paxlovid Rebound…